A Korean Post-Marketing Surveillance Study On Pergoveris® (Follitropin Alfa + Lutropin Alfa)
Clinical trial NCT01416987 · COMPLETED
Trial details
- NCT number
- NCT01416987
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2011-08-14
- Primary completion
- 2018-05-10
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.